
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Multi-component materials called magnetic nanocomposites often comprise nanosized magnetic components to stimulate a response in response to an external stimulus. Up until now, the pursuit of novel nanocomposites has resulted in the amalgamation of a wide range of various materials with various kinds of magnetic particles, opening up exciting possibilities for fundamental research as well as for application in a variety of fields, such as medical therapy and diagnosis, separations, actuation, or catalysis.
To emphasize broad ideas and recent developments in the creation of magnetic nanocomposites and the synthesis of magnetic nanoparticles, we have chosen a few of the most recent instances for this overview. Nanocomposites are multi-phasic materials that have units with at least one dimension smaller than 100 nm in the matrix material.
They blend the characteristics of the filler with the matrix material to create innovative functional materials that are tailored to the requirements of a specific application. In general, a wide variety of host materials, such as organic polymers, silica, or even liquid media, are used in nanohybrids.
Particularly interesting are host materials with adjustable characteristics that change in response to external stimuli. Due to a number of benefits, the use of magnetic fields as an external stimulus in this context has generated a lot of interest.
The Global Magnetic Nanocomposite Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Tailored launched a magnetic nanocomposite system made up of a cluster of magnetite nanoparticles with an average diameter of 140 20 nm. Using a variety of techniques, including chemical or physical conjugation of antibody molecules to either aminated MSNPs or carboxylated MSNPs, To separate exosomes from ultracentrifuge-enriched solution, PC3 cell-culture media, or exosome-spiked simulated plasma samples, MSNPs were next used.
Antibody-covalently conjugated MSNPs, specifically the AntiCD9-AMSNPs and AntiCD9-CMSNPs, were proven by quantitative testing using nanoparticle-tracking techniques to enable >90% recovery of exosomes.
Additionally, compared to AntiCD9-AMSNPs, the exosomes isolated using AntiCD9-CMSNPs demonstrated greater recovery efficiency. Less protein contaminants were found in both nanoadsorbents compared to exosomes separated using ultracentrifugation and the Exocib kit.
When compared to exosomes obtained using UC-enriched exosomes and the Exocib kit, the particles recovered utilizing AntiCD9-AMSNPs and AntiCD9-CMSNPs have smaller sizes, according to the mean diameter assessment of the isolated exosomes.
These encouraging exosome isolation results support the use of magnetic nanocomposite as a useful tool for the quick and easy isolation of exosomes for diagnostic purposes.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive Innovation in the Industry |
10 | Technology Trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in the US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on the point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End Use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in the past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in the past 12 months |
26 | M&A in the past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunities for new suppliers |
31 | Conclusion |
32 | Appendix |